+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Companion Diagnostics Market Analysis 2019

  • ID: 4857816
  • Report
  • October 2019
  • Region: Global
  • 144 pages
  • Syngene Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Almac Group
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • MORE
The Global Companion Diagnostics market is expected to reach $11.12 billion by 2026 growing at a CAGR of 17.7% from 2018 to 2026. A companion diagnostic is an in vitro medicinal device that provides data which is fundamental for the safe and effective utilization of a corresponding drug or biological product. This diagnostic test helps a health care professional to decide if a particular therapeutic product is beneficial to patients and can outweigh any potentially serious side effects or risks.

Some of the factors such as increasing importance of personalized medicine and rising global incidence of cancer are fuelling the market growth. However, uncertain reimbursement scenario in different regions is restraining the market growth.

Based on the technology, immunohistochemistry (IHC) segment has witnessed significant growth. Immunohistochemistry involves identification of antigens through antigen-antibody binding principle. This technology further allows evaluation of drug contingency with significant accuracy. Successful outcomes acquired with the use of immunohistochemistry technology will enlarge its preference, thereby propelling immunochemistry technology segment growth.

The key vendors mentioned are Thermo Fisher Scientific, Inc., Sysmex Corporation, QIAGEN N.V., Myriad Genetics, Inc., Illumina Inc., Guardant Health, Inc., F. Hoffmann-La Roche AG, Danaher Corporation, bioMérieux SA, Almac Group, Agilent Technologies, Inc.,
Abnova Corporation, and Abbott Laboratories, Inc.

Product & Services Covered:
  • Software & Services
  • Assays, Kits, & Reagents
Technologies Covered:
  • Polymerase Chain Reaction (PCR)
  • Molecular Diagnostics
  • Immunohistochemistry (IHC)
  • Next-Generation Sequencing (NGS)
  • In Situ Hybridization (ISH)
  • Gene Sequencing
  • Other Technologies
Indications Covered:
  • Virology
  • Neurological Diseases
  • Inflammation and Autoimmune Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Cancer
  • Other Indications
End Users Covered:
  • Reference Laboratories
  • Pharmaceutical & Biopharmaceutical Companies
  • Independent Clinical Laboratories
  • Contract Research Organizations
  • Other End Users
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analyzed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Almac Group
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Companion Diagnostics Market, By Product & Service
5.1 Introduction
5.2 Software & Services
5.3 Assays, Kits, & Reagents

6 Global Companion Diagnostics Market, By Technology
6.1 Introduction
6.2 Polymerase Chain Reaction (PCR)
6.3 Molecular Diagnostics
6.4 Immunohistochemistry (IHC)
6.5 Next-Generation Sequencing (NGS)
6.6 In Situ Hybridization (ISH)
6.7 Gene Sequencing
6.8 Other Technologies

7 Global Companion Diagnostics Market, By Indication
7.1 Introduction
7.2 Virology
7.3 Neurological Diseases
7.4 Inflammation and Autoimmune Diseases
7.5 Infectious Diseases
7.6 Cardiovascular Diseases
7.7 Cancer
7.8 Other Indications

8 Global Companion Diagnostics Market, By End User
8.1 Introduction
8.2 Reference Laboratories
8.3 Pharmaceutical & Biopharmaceutical Companies
8.4 Independent Clinical Laboratories
8.5 Contract Research Organizations
8.6 Other End Users

9 Global Companion Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 South America
9.6 Middle East & Africa

10 Strategic Benchmarking

11 Vendors Landscape
11.1 Thermo Fisher Scientific, Inc.
11.2 Sysmex Corporation
11.3 QIAGEN N.V.
11.4 Myriad Genetics, Inc.
11.5 Illumina Inc.
11.6 Guardant Health, Inc.
11.7 F. Hoffmann-La Roche AG
11.8 Danaher Corporation
11.9 bioMérieux SA
11.10 Almac Group
11.11 Agilent Technologies, Inc.
11.12 Abnova Corporation
11.13 Abbott Laboratories, Inc.

List of Data Tables
Table 1 Global Companion Diagnostics Market Outlook, By Region (2017-2026) ($MN)
Table 2 Global Companion Diagnostics Market Outlook, By Product & Service (2017-2026) ($MN)
Table 3 Global Companion Diagnostics Market Outlook, By Software & Services (2017-2026) ($MN)
Table 4 Global Companion Diagnostics Market Outlook, By Assays, Kits, & Reagents (2017-2026) ($MN)
Table 5 Global Companion Diagnostics Market Outlook, By Technology (2017-2026) ($MN)
Table 6 Global Companion Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2026) ($MN)
Table 7 Global Companion Diagnostics Market Outlook, By Molecular Diagnostics (2017-2026) ($MN)
Table 8 Global Companion Diagnostics Market Outlook, By Immunohistochemistry (IHC) (2017-2026) ($MN)
Table 9 Global Companion Diagnostics Market Outlook, By Next-Generation Sequencing (NGS) (2017-2026) ($MN)
Table 10 Global Companion Diagnostics Market Outlook, By In Situ Hybridization (ISH) (2017-2026) ($MN)
Table 11 Global Companion Diagnostics Market Outlook, By Gene Sequencing (2017-2026) ($MN)
Table 12 Global Companion Diagnostics Market Outlook, By Other Technologies (2017-2026) ($MN)
Table 13 Global Companion Diagnostics Market Outlook, By Indication (2017-2026) ($MN)
Table 14 Global Companion Diagnostics Market Outlook, By Virology (2017-2026) ($MN)
Table 15 Global Companion Diagnostics Market Outlook, By Neurological Diseases (2017-2026) ($MN)
Table 16 Global Companion Diagnostics Market Outlook, By Inflammation and Autoimmune Diseases (2017-2026) ($MN)
Table 17 Global Companion Diagnostics Market Outlook, By Infectious Diseases (2017-2026) ($MN)
Table 18 Global Companion Diagnostics Market Outlook, By Cardiovascular Diseases (2017-2026) ($MN)
Table 19 Global Companion Diagnostics Market Outlook, By Cancer (2017-2026) ($MN)
Table 20 Global Companion Diagnostics Market Outlook, By Other Indications (2017-2026) ($MN)
Table 21 Global Companion Diagnostics Market Outlook, By End User (2017-2026) ($MN)
Table 22 Global Companion Diagnostics Market Outlook, By Reference Laboratories (2017-2026) ($MN)
Table 23 Global Companion Diagnostics Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2017-2026) ($MN)
Table 24 Global Companion Diagnostics Market Outlook, By Independent Clinical Laboratories (2017-2026) ($MN)
Table 25 Global Companion Diagnostics Market Outlook, By Contract Research Organizations (2017-2026) ($MN)
Table 26 Global Companion Diagnostics Market Outlook, By Other End Users (2017-2026) ($MN)
Table 27 North America Companion Diagnostics Market Outlook, By Product & Service (2017-2026) ($MN)
Table 28 North America Companion Diagnostics Market Outlook, By Technology (2017-2026) ($MN)
Table 29 North America Companion Diagnostics Market Outlook, By Indication (2017-2026) ($MN)
Table 30 North America Companion Diagnostics Market Outlook, By End User (2017-2026) ($MN)
Table 31 Europe Companion Diagnostics Market Outlook, By Product & Service (2017-2026) ($MN)
Table 32 Europe Companion Diagnostics Market Outlook, By Technology (2017-2026) ($MN)
Table 33 Europe Companion Diagnostics Market Outlook, By Indication (2017-2026) ($MN)
Table 34 Europe Companion Diagnostics Market Outlook, By End User (2017-2026) ($MN)
Table 35 Asia Pacific Companion Diagnostics Market Outlook, By Product & Service (2017-2026) ($MN)
Table 36 Asia Pacific Companion Diagnostics Market Outlook, By Technology (2017-2026) ($MN)
Table 37 Asia Pacific Companion Diagnostics Market Outlook, By Indication (2017-2026) ($MN)
Table 38 Asia Pacific Companion Diagnostics Market Outlook, By End User (2017-2026) ($MN)
Table 39 South America Companion Diagnostics Market Outlook, By Product & Service (2017-2026) ($MN)
Table 40 South America Companion Diagnostics Market Outlook, By Technology (2017-2026) ($MN)
Table 41 South America Companion Diagnostics Market Outlook, By Indication (2017-2026) ($MN)
Table 42 South America Companion Diagnostics Market Outlook, By End User (2017-2026) ($MN)
Table 43 Middle East & Africa Companion Diagnostics Market Outlook, By Product & Service (2017-2026) ($MN)
Table 44 Middle East & Africa Companion Diagnostics Market Outlook, By Technology (2017-2026) ($MN)
Table 45 Middle East & Africa Companion Diagnostics Market Outlook, By Indication (2017-2026) ($MN)
Table 46 Middle East & Africa Companion Diagnostics Market Outlook, By End User (2017-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation
  • QIAGEN N.V.
  • Myriad Genetics, Inc.
  • Illumina Inc.
  • Guardant Health, Inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • bioMérieux SA
  • Almac Group
  • Agilent Technologies, Inc.
  • Abnova Corporation
  • Abbott Laboratories, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll